GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
This is a study to compare the safety, blood concentrations, and effects of GSK189075,
GW869682, and placebo when dosed for 2-weeks by mouth to patients with type 2 diabetes.